Pioneer in phage-based diagnostics

Twitter Youtube Linkedin Envelope
  • Home
  • About PBD Biotech
    • About
    • Research
    • Blog
  • Phage-based diagnostics
  • Animal Health
    • Animal Health
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Human Health
  • Contact us
  • Home
  • About PBD Biotech
    • About
    • Research
    • Blog
  • Phage-based diagnostics
  • Animal Health
    • Animal Health
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Human Health
  • Contact us
Actiphage TB awarded US Patent grant for diagnostic kit
Read more
Actiphage TB awarded US Patent grant for diagnostic kit
Actiphage TB enters third clinical trial.
Read more
“Significant association between positive Actiphage test and features of progressive TB infection.”
Read more
Lancet article - PET-CT features observed following M tuberculosis exposure. biomarkers show those at high risk of TB

Actiphage – Confidence
to test for active TB

Loading...
Actiphage TB diagnostic releases bacterial DNA for qPCR

Commercial opportunities with PBD Biotech

Lancet article - PET-CT features observed following M tuberculosis exposure. biomarkers show those at high risk of TB

Identifying people at risk of developing TB

Laboratory Support from PBD Biotech

New qPCR kit offers rapid Mycobacterial detection

Phage-based diagnostics

PBD Biotech specialises in the use of novel bacteriophage-based diagnostics.

The company has developed proprietary, patented technology that can be used to detect the presence of mycobacteria – the cause of tuberculosis in humans and animals – in a blood sample.

Our mission

PBD Biotech aims to drive innovation in the novel use of phages, such as Actiphage, for TB screening and drug management.

PBD Biotech developers of Actiphage TB

Contact us to discuss commercial opportunities

Latest

Loading...
Laboratory Support from PBD Biotech

New qPCR kit offers rapid Mycobacterial detection

July 2, 2025
NEW - Lyophilised qPCR Kit for Mycobacterium tuberculosis Complex Detection
Laboratory Support from PBD Biotech

New qPCR kit offers rapid Mycobacterial detection

July 2, 2025
NEW - Lyophilised qPCR Kit for Mycobacterium tuberculosis Complex Detection
No persistent cough in 4 out of 5 with Tuberculosis Lancet paper reveals

No persistent cough in 4 out of 5 with Tuberculosis Lancet paper reveals

March 21, 2024
80 percent of people with tuberculosis (TB), the world’s most deadly infection, do not have a persistent cough and yet are still infective, according to a study led by Amsterdam UMC, published in the Lancet. 
No persistent cough in 4 out of 5 with Tuberculosis Lancet paper reveals

No persistent cough in 4 out of 5 with Tuberculosis Lancet paper reveals

March 21, 2024
80 percent of people with tuberculosis (TB), the world’s most deadly infection, do not have a persistent cough and yet...
mycobacteria

Work by phage pioneers celebrated in World Antimicrobial Awareness Week

November 23, 2023
Dr Ben Swift has been awarded a Horizon award by AMI for his ground-breaking work developing a phage-based diagnostic for tuberculosis.
mycobacteria

Work by phage pioneers celebrated in World Antimicrobial Awareness Week

November 23, 2023
Dr Ben Swift has been awarded a Horizon award by AMI for his ground-breaking work developing a phage-based diagnostic for...
Certificate of Grant (web)

Actiphage TB patent granted in South Africa

November 14, 2023
Grant of a patent has been awarded to PBD Biotech for its Actiphage diagnostic for incipient tuberculosis in South Africa, this complements the regional West Africa patent gained earlier this year.
Certificate of Grant (web)

Actiphage TB patent granted in South Africa

November 14, 2023
Grant of a patent has been awarded to PBD Biotech for its Actiphage diagnostic for incipient tuberculosis in South Africa, this complements...
1 2

developers of phage-based diagnostics

Contact Us

Registered Company Address
B4 Parkside Knowledge Gateway
Nesfield Road
Colchester
CO4 3ZL
United Kingdom

info@pbdbio.com

BIVDA member 2023
Twitter Youtube Linkedin

Privacy and cookies policy

© 2025 PBD Biotech Ltd

design: out of house